Solu-Medrol
Showing 26 - 50 of 136
Complication, Postoperative Trial in Copenhagen (Methylprednisolone, Dexamethasone)
Completed
- Complication, Postoperative
-
Copenhagen, DenmarkRigshospitalet
Dec 8, 2020
Vasculitis Trial in Assiut (Ibuprofen, Prednisone, Methotrexate)
Unknown status
- Vasculitis
- Ibuprofen
- +2 more
-
Assiut, Upper Egypt, EgyptAssiut University Pediatric Hospital
Feb 12, 2021
Severe Ulcerative Colitis Patients Admitted for Intravenous
Unknown status
- Ulcerative Colitis
- Ultrasound Therapy; Complications
- Solu-Medrol
-
Copenhagen, Herlev, DenmarkHerlev University Hospital
Jan 26, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in Chicago (Cyclophosphamide, Mesna, rATG)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- Cyclophosphamide
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome Trial in Houston (BL-8040, horse anti-thymocyte globulin (hATG),
Completed
- Aplastic Anemia
- Hypoplastic Myelodysplastic Syndrome
- BL-8040
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 28, 2020
Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Stiff-Person Syndrome
- Autologous Hematopoietic Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Hernia, Ventral Trial in Copenhagen NV (Methyl-Prednisolone, Physiological saline)
Completed
- Hernia, Ventral
- Methyl-Prednisolone
- Physiological saline
-
Copenhagen NV, Copenhagen, DenmarkBispebjerg Hospital
Sep 27, 2020
Systemic Sclerosis, Scleroderma Trial in Chicago (Rituximab, Fludarabine, Cyclophosphamide)
Exercise Performance in Copd Patients Trial in Copenhagen (prednisone)
Completed
- Exercise Performance in Copd Patients
-
Copenhagen, NV, DenmarkBispebjerg Hospital
Jan 31, 2020
Scleroderma, Systemic Trial in Chicago (Peripheral Blood Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Scleroderma, Systemic
- Peripheral Blood Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jul 7, 2020
Devic's Disease Trial in Chicago (Hematopoietic Stem Cell Transplantation, Cyclophosphamide, G-CSF)
Completed
- Devic's Disease
- Hematopoietic Stem Cell Transplantation
- +6 more
-
Chicago, IllinoisNorthwestern University, Feinberg School of Medicine
Feb 17, 2020
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
Rheumatoid Arthritis Trial in Leeds (Infliximab, Methylprednisolone, Methotrexate)
Completed
- Rheumatoid Arthritis
- Infliximab
- +3 more
-
Leeds, West Yorkshire, United KingdomChapel Allerton Hospital
Oct 30, 2019
Systemic Sclerosis, Raynaud Phenomena Trial in Nijmegen (Methylprednisolone, sodium chloride)
Unknown status
- Systemic Sclerosis
- Raynaud Phenomena
- Methylprednisolone
- sodium chloride
-
Nijmegen, Gelderland, NetherlandsRadboudumc, Rheumatology department
Nov 27, 2019
Chronic Graft-versus-host Disease Trial in Worldwide (Itacitinib, Placebo, Methylprednisolone)
Active, not recruiting
- Chronic Graft-versus-host Disease
- Itacitinib
- +3 more
-
Tucson, Arizona
- +132 more
Oct 17, 2022
Drug Interaction Potentiation Trial in Taipei (Everolimus, Mycophenolate mofetil, Tacrolimus)
Completed
- Drug Interaction Potentiation
- Everolimus
- +4 more
-
Taipei, TaiwanNational Taiwan University Hospital
Jul 22, 2019
Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)
Terminated
- Leukemia
- +2 more
- Fludarabine
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 24, 2019
Lymphoma Trial in Tucson (Methylprednisolone, Etoposide, Cytarabine)
Completed
- Lymphoma
- Methylprednisolone
- +6 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Aug 23, 2019
Sensorineural Hearing Loss, Tinnitus Trial (Combination Solution)
Not yet recruiting
- Sensorineural Hearing Loss
- Tinnitus
- Combination Solution
- (no location specified)
Sep 7, 2023
Neuromyelitis Optica Trial in Stanford (Alpha1-antitrypsin, methylprednisolone)
Withdrawn
- Neuromyelitis Optica
-
Stanford, CaliforniaStanford University
Apr 10, 2019
Graft-versus-host Disease (GVHD) Trial in Worldwide (Itacitinib, Placebo, Prednisone)
Completed
- Graft-versus-host Disease (GVHD)
- Itacitinib
- +3 more
-
La Jolla, California
- +128 more
Jul 13, 2021
Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Everolimus (RAD001), Cyclophosphamide, Vincristine)
Completed
- Leukemia
- Acute Lymphocytic Leukemia
- Everolimus (RAD001)
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 5, 2019
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)
Completed
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Cyclophosphamide
- +16 more
-
Portland, OregonOHSU Knight Cancer Institute
May 21, 2020